Figure 1.
Splenic DC populations and maturation in culture. (A) Mouse spleens contain 3 populations of CD11c+ DCs that can be distinguished by their expression of CD4 and CD8: CD4+ DCs, CD8+ DCs, and CD4–CD8– DCs. (B) FACS analysis of MHC II and CD86 expression in splenic DCs freshly isolated (f, thin continuous line) or after overnight culture (o/n, thick line). The dashed line corresponds to unlabeled cells (b, background). The histograms correspond to the whole spleen DC preparation; the results were similar for each of the 3 splenic DC subtypes. (C) Immunofluorescence confocal microscopy (ICM) analysis of I-Ab (red) and lysosome-associated membrane protein–1 (Lamp 1) (green) localization in splenic CD8+ DCs freshly isolated (left panels) or after culture for 18 hours (right panels). The dye DAPI (4′,6 diamidino-2-phenylindole) (blue) was included to label the nuclei. Original magnification, × 63. Similar results were obtained with CD4+ DCs and CD4–CD8– DCs (not shown). (D) Left bar: 5 × 103 purified CD8+ DCs were incubated with 50 μg/mL OVA for 45 minutes, washed, and then incubated with naive OVA-specific OT-II cells labeled with CFSE. After 2.5 days in culture, the number of proliferating OT-II cells (propidium iodide [PI]– CFSElow) was determined by FACS analysis. Central bar: after the incubation with OVA, the CD8+ DCs were washed, cultured for 16 hours, and then incubated with OT-II cells for 2.5 days. Right bar: the CD8+ DCs were first cultured for 16 hours and then incubated with OVA for 45 minutes, washed, and incubated with the OT-II cells for 2.5 days. Similar results were obtained with CD8– DCs (not shown).25 (E) Splenic DCs were fixed in PFA immediately after purification (dashed line) or after overnight culture (continuous line) and then incubated with CFSE-labeled OT-II cells in the presence of 0.1 μg/mL OVA323-339 peptide. OT-II proliferation was determined 2.5 days later. Data for experiments in D and E were obtained in duplicate; bars represent the range of the values obtained.